...
首页> 外文期刊>Journal of Huazhong University of Science and Technology >Inducement of Specific CTLs by Antigen-Peptides from Human Leukemia Cells and Their Cytotoxicity to Leukemia Cells
【24h】

Inducement of Specific CTLs by Antigen-Peptides from Human Leukemia Cells and Their Cytotoxicity to Leukemia Cells

机译:人白血病细胞抗原肽诱导特定CTLs及其对白血病细胞的细胞毒性

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

To investigate the inducement of cytotoxic T lymphocytes (CTLs) by antigen peptides mixture from different leukemia cells and the cross-reaction of the mixtures from different cell lines, antigen peptides mixtures were prepared from different leukemia cell lines respectively and then hound with Hsp70 in vitro. Activation and proliferation of PBMC were observed after stimulation with different Hsp70-peptide complexes. The ratio of CD8~+ in proliferative cells was analyzed hy flow cytometry. The cytotoxicity of the activated PBMC to different target cells was assayed. The results showed that the antigen peptides from different leukemia cell lines, bound with Hsp70, could activate PBMC effectively, and stimulate the activated PBMC to proliferate. The proliferative PBMC had specific cytotoxicity to corresponding leukemia cells. CD8~+ cells, accounting for a high proportion in proliferative cells, had a specific cytotoxicity to leukemia cells from which antigen peptides were prepared, suggesting that these CD8~+ cells were CTLs specific to leukemia cells. CTLs activated hy Hut78-peptides or Molt4-peptides had a significantly stronger cytotoxicity to Hut78 cells. Molt 1 cells and Jurkat cells than that of CTLs activated by HL-60-peptides (P<0, 05). Arid the cytotoxicity of CTLs activated by Hut78/Molt4-peptides to Jurkat cells was significantly stronger than that of CTLs activated by either Hut78-peptides or Molt4-peptides alone (P<0.05). It is concluded that antigen peptides mixtures from leukemia cells can induce specific antitumor CTLs. There exists cross-reactivity among antigen peptides mixtures from different cell lines of the same type leukemia and more cross-reactive antigen peptides could be obtained from more cell lines, suggesting that antigen peptides mixture with broad antigenic spectrum could be prepared by using multiple leukemia cell lines.
机译:为了研究不同白血病细胞的抗原肽混合物对细胞毒性T淋巴细胞(CTL)的诱导作用以及不同细胞系混合物的交叉反应,分别从不同的白血病细胞系中制备抗原肽混合物,然后在体外用Hsp70进行猎犬。在用不同的Hsp70-肽复合物刺激后,观察到PBMC的活化和增殖。流式细胞仪分析了CD8 +在增殖细胞中的比例。测定了活化的PBMC对不同靶细胞的细胞毒性。结果表明,来自不同白血病细胞系的抗原肽与Hsp70结合,可以有效激活PBMC,并刺激激活的PBMC增殖。增殖性PBMC对相应的白血病细胞具有特异性细胞毒性。 CD8 +细胞在增殖细胞中占很高的比例,对制备抗原肽的白血病细胞具有特定的细胞毒性,表明这些CD8 +细胞是白血病细胞特异的CTL。 CTL激活的Hyt78肽或Molt4肽对Hut78细胞具有明显更强的细胞毒性。与被HL-60肽激活的CTL相比,蜕皮1细胞和Jurkat细胞(P <0,05)。由Hut78 / Molt4肽激活的CTL对Jurkat细胞的干旱细胞毒性明显强于由Hut78肽或单独的Molt4肽激活的CTL(P <0.05)。结论是来自白血病细胞的抗原肽混合物可以诱导特异性抗肿瘤CTL。同一类型白血病不同细胞株的抗原肽混合物之间存在交叉反应,可以从更多细胞株中获得更多的交叉反应抗原肽,这表明使用多种白血病细胞可以制备具有广泛抗原谱的抗原肽混合物。线。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号